News & Press
China's brain-computer interface industry is racing ahead
TechCrunch2/22/2026ยท02/22/26๐ Asia
Summary
China's BCI industry is moving from research to scale, with startups like NeuroXess and Gestala racing to commercialize both implantable and noninvasive BCIs. Multiple provinces have set medical service pricing for BCI procedures, and the market was expected to reach $530 million in 2025. StairMed raised $48 million Series B in February 2025 and BrainCo filed for a Hong Kong IPO.
Why it matters
China's coordinated policy support, clinical resources, and manufacturing capacity are creating a comprehensive BCI ecosystem that could challenge US leaders like Neuralink and Synchron. The inclusion of BCI in medical insurance coverage solves a major adoption barrier.
#BCI#Neural Interfaces#Industry#China#Asia#Venture Capital
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items โ updated daily.
Start free trialAlready a member? Sign in